Argatroban, specific thrombin inhibitor, induced phenotype change of cultured rabbit vascular smooth muscle cells

European Journal of Pharmacology

Volumn 461, Issue 1, 2003, Pages 9-17

  Yoshinaga, Masatomi ^a   Sunagawa, Masanori ^a   Shimada, Seiji ^a   Nakamura, Mariko ^a   Murayama, Sadayuki ^a   Kosugi, Tadayoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Argatroban; In situ hybridization; PDGF, (platelet derived growth factor); RT PCR, (reverse transcription polymerase chain reaction); Smooth muscle cell, vascular

Indexed keywords

ARGATROBAN; BETA ACTIN; MESSENGER RNA; MYOSIN HEAVY CHAIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; RNA; THROMBIN INHIBITOR;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; IN SITU HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; UPREGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0037423071     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01293-7     Document Type: Article

References (32)

1. Aikawa M., Sivam P.N., Kuro-o M., Kimura K., Nakahara K., Takewaki S., Ueda M., Yamaguchi H., Yazaki Y., Periasamy M. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ. Res. 73:1993;1000-1012.
2. Arno H.M., Levi M., Peters R.J.G. Tissue factor and coronary restenosis. Cardiovasc. Res. 53:2002;313-325.
3. Babij P., Kawamoto S., White S., Adelstein R.S., Periasamy M. Differential expression of SM1 and SM2 myosin isoforms in cultured vascular smooth muscle. Am. J. Physiol. 262:1992;C607-C613.
4. Bauters C., Meurice T., Hamon M., McFadden E., Lablanche J.-M., Bertrand M.E. Mechanisms and prevention of restenosis: from experimental models to clinical practice. Cardiovasc. Res. 31:1996;835-836.
5. Blank R.S., Swartz E.A., Thompson M.M., Olson E.N., Owens G.K. A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics. Circ. Res. 76:1995;742-749.
6. Borrione A.C., Zanellato A.M., Scannapieco G., Pauletto P., Sartore S. Myosin heavy-chain isoforms in adult and developing rabbit vascular smooth muscle. Eur. J. Biochem. 183:1989;413-417.
7. Burchenal J.E.B., Marks D.S., Mann J.T., Schweiger M.J., Rothman M.T., Ganz P., Adelman B., Bittl J.A. Effect of direct thrombin inhibition with bivalirudin (Hirulog) on restenosis after coronary angioplasty. Am. J. Cardiol. 82:1998;511-515.
8. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
9. Hayashi A., Suzuki T., Tajima S. Modulations of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells. J. Biochem. (Tokyo). 117:1995;132-136.
10. Hayashi K., Takahashi M., Kimura K., Nishida W., Saga H., Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogens-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J. Cell. Biol. 145:1999;740-772.
11. Hu Y., Cheng L., Hochleitner B.W., Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 17:1996;2808-2816.
12. Imanishi T., Arita M., Tomobuchi Y., Hamada M., Hano T., Nishio I. Effects of locally administered argatroban on restenosis after balloon angioplasty: experimental and clinical study. Clin. Exp. Pharmacol. Physiol. 24:1997;800-806.
13. Ip J.H., Fuster V., Israel D., Badimon L., Badimon J., Chesebro J.H. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J. Am. Coll. Cardiol. 17:1991;77B-88B.
14. Kocher O., Skalli O., Bloom W.S., Gabbiani G. Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening. Lab. Invest. 50:1984;645-652.
15. Kuro-o M., Nagai R., Nakahara K., Katoh H., Tsai R.C., Tsuchimochi H., Yazaki Y., Ohkubo A., Takaku F. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J. Biol. Chem. 266:1991;3768-3773.
16. Miano J.M., Cserjesi P., Ligon K.L., Periasamy M., Olson E.N. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ. Res. 75:1994;803-812.
17. Moledina M., Chakir M., Gandhi P.J. A synopsis of the clinical uses of argatroban. J. Thromb. Thrombolysis. 12:2001;141-149.
18. Nagai R., Suzuki T., Aizawa K., Miyamoto S., Amaki T., Kawai-Kowase K., Sekiguchi K.I., Kurabayashi M. Phenotypic modulation of vascular smooth muscle cells: dissection of transcriptional regulatory mechanisms. Ann. N.Y. Acad. Sci. 947:2001;56-66.
19. Okamoto S., Hijikata A., Kikumoto R., Tonomara S., Hara H., Ninomiya K., Maruyama A., Sugano M., Tamao Y. Potent inhibition of thrombin by the newly synthesized arginine derivative no. 805. The importance of stereostructure of its hydrophobic carboxamide portion. Biochem. Biophys. Res. Commun. 101:1981;440-446.
20. Okamoto E., Imataka K., Fujii J., Kuro-o M., Nakahara K., Nishimura H., Yazaki Y., Nagai R. Heterogeneity in smooth muscle cell population accumulating in the neointimas and the media of poststenotic dilatation of the rabbit carotid artery. Biochem. Biophys. Res. Commun. 185:1992;459-464.
21. Okayama H., Kawaischi M., Brownstein M., Lee F., Yokota T., Arai K. High-efficiency cloning of full-length cDNA; Construction and screening of cDNA expression libraries for mammalian cells. Wu R., Grossmann L. Methods Enzymol. vol. 154:1987;3-28 Academic Press, San Diego.
22. Pyles J.M., March K.L., Franklin M., Mehdi K., Wilenski R.L., Adam L.P. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ. Res. 81:1997;904-910.
23. Raap A.K., Van de Rijke F.M., Dirks R.W., Sol C.J. Bicolor fluorescence in situ hybridization to intron- and exon mRNA sequences. Exp. Cell Res. 197:1991;319-322.
24. Reusch H.P., Zimmermann S., Schaefer M., Paul M., Moelling K. Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells. J. Biol. Chem. 276:2001;33630-33637.
25. Rovner A.S., Thompson M.M., Murphy R.A. Two different heavy chains are found in smooth muscle myosin. Am. J. Physiol. 250:1986;C861-C870.
26. Simons M., Rosenberg R.D. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res. 70:1992;835-843.
27. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int. Rev. Cytol. 169:1996;183-265.
28. Topol E.J., Serruys P.W. Frontiers in interventional cardiology. Circulation. 98:1998;1802-1820.
29. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4350-4354.
30. Ueki Y., Matsumoto K., Kizaki Y., Yoshida K., Matsunaga Y., Yano M., Miyake S., Tominaga Y., Eguchi K. Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease: placebo-controlled study. J. Thromb. Thrombolysis. 8:1999;131-137.
31. Yoshida Y., Mitsumata M., Yamane T., Tomikawa M., Nishida K. Morphology and increased growth rate of atherosclerotic intimal smooth-muscle cells. Arch. Pathol. Lab. Med. 112:1988;987.
32. Zhang Z., Nagata I., Kikuchi H., Xue J.-H., Sakai N., Sakai H., Yanamoto H. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB. Stroke. 32:2001;1665-1672.